193 related articles for article (PubMed ID: 32324169)
1. B-type natriuretic peptide is upregulated by c-Jun N-terminal kinase and contributes to septic hypotension.
Hoffman M; Kyriazis ID; Dimitriou A; Mishra SK; Koch WJ; Drosatos K
JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32324169
[TBL] [Abstract][Full Text] [Related]
2. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
[TBL] [Abstract][Full Text] [Related]
3. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
Abdelhamid G; El-Kadi AO
Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
[TBL] [Abstract][Full Text] [Related]
5. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock.
Kandil E; Burack J; Sawas A; Bibawy H; Schwartzman A; Zenilman ME; Bluth MH
Arch Surg; 2008 Mar; 143(3):242-6; discussion 246. PubMed ID: 18347270
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation.
Takahashi N; Saito Y; Kuwahara K; Harada M; Kishimoto I; Ogawa Y; Kawakami R; Nakagawa Y; Nakanishi M; Nakao K
Hypertens Res; 2003 Oct; 26(10):847-53. PubMed ID: 14621189
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of brain natriuretic peptide (BNP) in non-cardiac patients with sepsis, ultra-long follow-up.
Khoury J; Arow M; Elias A; Makhoul BF; Berger G; Kaplan M; Mashiach T; Ismael-Badarneh R; Aronson D; Azzam ZS
J Crit Care; 2017 Dec; 42():117-122. PubMed ID: 28719839
[TBL] [Abstract][Full Text] [Related]
9. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
[TBL] [Abstract][Full Text] [Related]
10. Signaling mechanisms underlying strain-dependent brain natriuretic peptide gene transcription.
Liang F; Kovacic-Milivojevic B; Chen S; Cui J; Roediger F; Intengan H; Gardner DG
Can J Physiol Pharmacol; 2001 Aug; 79(8):640-5. PubMed ID: 11558672
[TBL] [Abstract][Full Text] [Related]
11. Atrial and brain natriuretic peptides: Hormones secreted from the heart.
Nakagawa Y; Nishikimi T; Kuwahara K
Peptides; 2019 Jan; 111():18-25. PubMed ID: 29859763
[TBL] [Abstract][Full Text] [Related]
12. Correlations of Changes in Brain Natriuretic Peptide (BNP) and Cardiac Troponin I (cTnI) with Levels of C-Reactive Protein (CRP) and TNF-α in Pediatric Patients with Sepsis.
Zhang Y; Luo Y; Nijiatijiang G; Balati K; Tuerdi Y; Liu L
Med Sci Monit; 2019 Apr; 25():2561-2566. PubMed ID: 30956276
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.
Lee S; Das HK
Brain Res; 2008 May; 1207():19-31. PubMed ID: 18374905
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of the B-type natriuretic peptide mRNA in cardiac myocytes by alpha-adrenergic receptor activation: potential roles for protein kinase C and mitogen-activated protein kinase.
Hanford DS; Glembotski CC
Mol Endocrinol; 1996 Dec; 10(12):1719-27. PubMed ID: 8961280
[TBL] [Abstract][Full Text] [Related]
15. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase.
Ma KK; Ogawa T; de Bold AJ
J Mol Cell Cardiol; 2004 Apr; 36(4):505-13. PubMed ID: 15081310
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and β-arrestin 2.
Zhou Y; Song Y; Shaikh Z; Li H; Zhang H; Caudle Y; Zheng S; Yan H; Hu D; Stuart C; Yin D
Oncotarget; 2017 Jul; 8(29):47317-47329. PubMed ID: 28525390
[TBL] [Abstract][Full Text] [Related]
17. M-CAT element mediates mechanical stretch-activated transcription of B-type natriuretic peptide via ERK activation.
Koivisto E; Karkkola L; Majalahti T; Aro J; Tokola H; Kerkelä R; Ruskoaho H
Can J Physiol Pharmacol; 2011 Aug; 89(8):539-50. PubMed ID: 21812548
[TBL] [Abstract][Full Text] [Related]
18. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality.
Klouche K; Pommet S; Amigues L; Bargnoux AS; Dupuy AM; Machado S; Serveaux-Delous M; Morena M; Jonquet O; Cristol JP
J Intensive Care Med; 2014; 29(4):229-37. PubMed ID: 23753226
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes.
He Q; LaPointe MC
Hypertension; 1999 Jan; 33(1 Pt 2):283-9. PubMed ID: 9931118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
